You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR LAMIVUDINE; RALTEGRAVIR POTASSIUM

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for LAMIVUDINE; RALTEGRAVIR POTASSIUM

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01105611 ↗	Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users	Unknown status	St. James's Hospital, Ireland	Phase 4	2010-08-01	The purpose of this study is to compare how safe, tolerable, and effective a novel drug, raltegravir, is to a commonly used combination, atazanavir/ritonavir, as initial treatment in HIV/Hepatitis C co-infected injecting drug users on a methadone program.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for LAMIVUDINE; RALTEGRAVIR POTASSIUM

Condition Name

Chart
Table

Condition Name for LAMIVUDINE; RALTEGRAVIR POTASSIUM
Intervention	Trials
Hepatitis C	1
HIV Infections	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for LAMIVUDINE; RALTEGRAVIR POTASSIUM
Intervention	Trials
HIV Infections	1
Hepatitis C	1
Hepatitis A	1
Hepatitis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for LAMIVUDINE; RALTEGRAVIR POTASSIUM

Trials by Country

Map
Table

Trials by Country for LAMIVUDINE; RALTEGRAVIR POTASSIUM
Location	Trials
Ireland	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for LAMIVUDINE; RALTEGRAVIR POTASSIUM

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for LAMIVUDINE; RALTEGRAVIR POTASSIUM
Clinical Trial Phase	Trials
Phase 4	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for LAMIVUDINE; RALTEGRAVIR POTASSIUM
Clinical Trial Phase	Trials
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LAMIVUDINE; RALTEGRAVIR POTASSIUM

Sponsor Name

Chart
Table

Sponsor Name for LAMIVUDINE; RALTEGRAVIR POTASSIUM
Sponsor	Trials
St. James's Hospital, Ireland	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for LAMIVUDINE; RALTEGRAVIR POTASSIUM
Sponsor	Trials
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.